CRISPR Insider™

CRISPR News From Around The World

< CRISPR Insider™ home

Home Page

Crispr News

Crispr Therapeutics (NASDAQ:CRSP) Cut to Sell at BidaskClub - Riverton Roll
January 26, 2020
Hit pause on gene editing - NWAOnline
January 26, 2020
Russian expert is ready to comment on the coronavirus - Newswise
January 25, 2020
DNA sleuths read the coronavirus genome, tracing its origins - STAT
January 25, 2020
Bayer cuts stake in CRISPR Therapeutics - Seeking Alpha
January 24, 2020
Tech 24 - CRISPR-Cas9: The era of genome editing - FRANCE 24
January 24, 2020
Can CRISPR Save Tufty Fluffytail? - JSTOR Daily
January 24, 2020
Unstoppable Stocks Review: Compania de Minas Buenaventura S.A.A. (BVN) and CRISPR Therapeutics AG (CRSP) - BOV News
January 24, 2020
Analysis: Broad Institute Loses Appeal on European CRISPR... - Labiotech.eu
January 24, 2020
Biotech industry aims to avoid backlash from GMO-wary consumers as CRISPR-edited crops near mass commercialization - Genetic Literacy Project
January 24, 2020
UC Berkeley professor Jennifer Doudna wins 2020 Wolf Prize in Medicine - Daily Californian
January 23, 2020
CRISPR gene editing could help stop a common poultry virus in its tracks - Digital Trends
January 23, 2020
RSI Alert: CRISPR Therapeutics (CRSP) Now Oversold - Nasdaq
January 23, 2020
Disabling viruses with CRISPR scissors - WSU News
January 23, 2020
CRISPR Has The Potential To Improve Lives. But At What Cost? - WBUR
January 23, 2020
'Does intrinsically good and bad technology exist?' Bayer CEO says no: Davos 2020 - FierceBiotech
January 22, 2020
Emendo Eyes the Clinic for CRISPR Therapy That Makes Single-Gene Edits - Xconomy
January 22, 2020
Loss of Patent Rights in EPO on CRISPR - Patently-O
January 22, 2020
Lessons from CRISPR: Getting your European priorities straight - Lexology
January 21, 2020
Drug profiling and gene scissors open new avenues in immunotherapy - Science Daily
January 21, 2020

CRISPRInsider.com is a global news aggregation platform dedicated to disseminating information about research and scientific discoveries from the transformative CRISPR scientific research community, as well as legal, business and regulatory news pertaining to the field.

Part 1 – Dr. George Church, Professor at MIT & Harvard. Topics: how the Human Genome Project led to CRISPR gene editing; consumer uses of genetic information; immunotherapy. Boston, June 5, 2018

Part 2 – Dr. George Church, Professor at Harvard & MIT. Topics: Can CRISPR gene editing reinvent man?; most desireable genes; unintended consequences; treating cancer; CRISPR preps pigs for transplantation. Boston, June 5, 2018

Part 3 – Dr. George Church. Topics: FDA hold on CRISPR clinical trial; sickle cell & thalassemia. Boston, June 5, 2018

Part 4 – Dr. George Church: CRISPR “very exciting for plant and animal agriculture.” Boston, June 5, 2018

Part 5 – Dr. George Church: Monitor the spread of synthetic biology: “There should be licensing and surveillance.” Boston, June 5, 2018

Part 6 – Dr. George Church: “The most important thing about CRISPR is that it will be replaced.” Boston, June 5, 2018

Dr. Feng Zhang discusses his work at CRISPRcon18. Boston, June 4, 2018

Dr. Duanqing Pei, Chinese Academy of Sciences: Why Chinese CRISPR research is focusing on Beta Thalassemia and Sickle Cell Diseases. Boston, June 5, 2018

Dr. Duanqing Pei, Chinese Academy of Sciences: Clinical trials guidelines and principles “closely related” in U.S. and China. Boston, June 5, 2018

Pat 1, Mice Against Ticks. Can CRISPR gene editing wipe out Lyme Disease? Carrie Fyler, PhD, comments. Boston, June 5, 2018. 2:34.

Part 2, Mice Against Ticks. A Massachusetts biology teacher offers a possible timeline for a test plan to eradicate Lyme Disease on Martha’s Vineyard and Nantucket Islands. Boston, June 5, 2018. 4:11

Part 3, Mice Against Ticks. How the public has responded, so far, to the Mice Against Ticks gene editing proposal. Boston, June 5, 2018. :43

Mice Against Ticks, Part 4. How Lyme Disease could get stopped on Martha’s Vineyard and Nantucket Islands using the gene editing tool CRISPR CAS9 on field mice to reduce the incidence of this tick-borne disease. Boston, June 5, 2018. :51

Dr. Tom Barnes, Intellia Therapeutics: Why recent CRISPR CAS9/Cancer headlines are “unwarranted.” NYC, June 21, 2018

Dr. Tom Barnes, Intellia Therapeutics, assesses the CRISPR clinical push in China. NYC, June 21, 2018. 1:45

Dr. Tom Barnes, Intellia Therapeutics: FDA’s hold on CTX0001 “might be nothing.” NYC, June 21, 2018. :47

Dr. Tom Barnes, Intellia Therapeutics, addresses the cost complexities of personalized medicine. NYC, June 21, 2018

Dr. Tom Barnes, Intellia Therapeutics, discusses newest CRISPR Cas9 U.S. patent for Doudna and Charpentier. NYC, June 21, 2018

Dr. Tom Barnes, Intellia Therapeutics: The areas we’re’ working on with CRISPR. NYC, June 21, 2018

Search for:

CRISPR News from China

“Cool new app”CRISPR technology can repair sperm defects perfect baby is getting closer
July 8, 2018
CRISPR adjustable butterfly wings the color and the flake structure! Or will be used for manufacturing bright colors…
July 7, 2018
“Cool new app”CRISPR technology can repair sperm defects perfect baby is getting closer
July 7, 2018
The new CRISPR technology can repair sperm defects,perfect baby is getting closer
July 6, 2018
Two papers confirmed:“the magic cut”CRISPR can accurately assess heart disease genetic testing results
June 29, 2018
Tongji University joined Merck CRISPR core Partnership project
June 27, 2018
Using“magic scissors”CRISPR technology could heal the 7 types of diseases
June 27, 2018
Scientists complete the CRISPR-Cas13a mediated precise site-directed RNA editing of the manual machine
June 22, 2018
Shattered hopes? Studies show that CRISPR has a serious defect,or cause the body to lose anti-cancer capacity
June 20, 2018
CRISPR/Cas9 presence of a carcinogenic risk? Rest assured,this is still just a conjecture
June 20, 2018
Suspected carcinogenic! Today’s most powerful, the most valuable gene editing technology CRISPR,exactly what happened?
June 16, 2018
Carcinogenic panic gripped“gene magic cut”: the Nature of the sub-issue bursts of two messages,CRISPR successful…
June 14, 2018
Two Nat Med induced CRISPR stock plunge,this is because p53
June 13, 2018
CRISPR gene editing therapy for fear of cancer causing,related to the industry slumped 13%
June 13, 2018
CRISPR exposure vulnerability! Gene edited cells or potential cancer cells
June 13, 2018

Contact

Your Name (required)

Your Email (required)

Subject

Your Message

Copyright 2018 CrisprInsider.com